ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000710.1|Neomycin_1 # 1 # 1296 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.802	BGC0000710.1|Neomycin_1 	1	1296	+	Loose	450	26.1794	ANT(9)-Ia	38.89	3002630	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(9)	GAGGCCATGCCGCGCCGCCTGCCGCCCGGTGCGGCGCTGGTCCTGGTGGACGACCAGCCGGACACCGGTGCCACCGCCCTCGCCGTGCGCGACCGGGTCGCCCGGCGCTATCCGGGCGTGCGGGACGTCGTCCTGGCCGCGCCGGGTCGGCTCTACGACCTGAGCGGCCCGGCCGTCCGCCCGCTGGCCGAGCGGCCGGTCGTCCGCCCGGCGGCCCGCCTGTGGCAGCTCGCCGGCACGGGCGGCGCCGCCGCGCTCGCGGCCCGCGCACGGGCGGCGGGCGTGCCCCTCGCACCGGGCGCCGCCCACCGCGTGGAGCCGTTCCGGGGCCCCTTCCTCGCGGAGTACGGGCCGGGCACCGCCCCGCGCGGGGGCGCCGCCGGCGCGCGCGGGAGCGGCGCGGCCCGCCGCCTCGATCCCCGCAACCGGCCCTTCTCCCTGGTCGCCGGTGCGACGGGCGCGGGCACGAGCGGCGGTACGGGCGCCCCGGAGACGTACCACTTCCGCTTCATCGGCACCGGACCGCACGGCCTCCACTGCCACCAGGCCCTGCGCGCCCTGGGGGACCTGCTCCCGCCCGGCCACGTCTTCGCCGACGGCTACCTGGTGACCCGCCACGAGCACGGGCTGCGCCCGCTGCGCGCGGTACTGCCGGAGCTGGAGGAGCCGCGGCGGCGCCGCGTACTGCTCGCGGTCGCCGAGTCCTGGGCCGCGCTGCGCCGCGTCGGCGAGCTGGGCCGTCCGGGCGCGGGCGCCGGGTACGAGCCGCGGGCCCGGCTCGACGGGGCGCTGCGGCGACTGCGCGAGCGCATGGGCCGGCCCCTGCCCGTCGACGGCGCCTGGACGGCCCGGCACGTGCCGGAGCGGATGCCCCTCGGGGGCGCCGACGGGGTGCTGCTGCGCACCCCGCTTCCATACGGGCACGGGTACTGGCACTGGCAGCTCGCGGACACCGGCCAGGGGGGCGCGGGTCCCGCGGGCGGCGGCGCCCCGGTTCTGCGGCGGTTCGGGCTGGACTGGATCTGGGGCGGCGGCGGCTGCCTGGAGAGCGAGATCGCCTCCTTCGTCGTCGAGAACCGGCTCGGCGCCCATGACCGGGACCTGCTGCGGGAGGCCGTCGCCGCGGCCTGCGGCGGTACGCGCGCCTTCGACGCCGGGCTGCGGCTGGCGGGCGAGGCGCTGTTCTGGAACGCCAAGACGTGGCTGCGGCGCTGCCCGGTCGTCACGCCGCCCACCGCCGACCGGATCGAGGCGGAGCTGGCCGCCCAGGCCGCGTACGTCGCCGCACTGGCCTGA	EAMPRRLPPGAALVLVDDQPDTGATALAVRDRVARRYPGVRDVVLAAPGRLYDLSGPAVRPLAERPVVRPAARLWQLAGTGGAAALAARARAAGVPLAPGAAHRVEPFRGPFLAEYGPGTAPRGGAAGARGSGAARRLDPRNRPFSLVAGATGAGTSGGTGAPETYHFRFIGTGPHGLHCHQALRALGDLLPPGHVFADGYLVTRHEHGLRPLRAVLPELEEPRRRRVLLAVAESWAALRRVGELGRPGAGAGYEPRARLDGALRRLRERMGRPLPVDGAWTARHVPERMPLGGADGVLLRTPLPYGHGYWHWQLADTGQGGAGPAGGGAPVLRRFGLDWIWGGGGCLESEIASFVVENRLGAHDRDLLREAVAAACGGTRAFDAGLRLAGEALFWNAKTWLRRCPVVTPPTADRIEAELAAQAAYVAALA	MSNLINGKIPNQAIQTLKIVKDLFGSSIVGVYLFGSAVNGGLRINSDVDVLVVVNHSLPQLTRKKLTERLMTISGKIGNTDSVRPLEVTVINRSEVVPWQYPPKREFIYGEWLRGEFENGQIQEPSYDPDLAIVLAQARKNSISLFGPDSSSILVSVPLTDIRRAIKDSLPELIEGIKGDERNVILTLARMWQTVTTGEITSKDVAAEWAIPLLPKEHVTLLDIARKGYRGECDDKWEGLYSKVKALVKYMKNSIETSLN	165.77	gnl|BL_ORD_ID|1270|hsp_num:0	1386			540	645	spectinomycin
BGC0000710.1|Neomycin_2 # 1494 # 2333 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=9bp;gc_cont=0.789	BGC0000710.1|Neomycin_2 	1494	2333	-	Loose	700	26.9498	mdtM	29.63	3001214	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; lincosamide antibiotic; nucleoside antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGGTGAGCCGACGTGGGAGGCGGCGGAGGACCCCGACCGGACGCTGCGGGAGCGGCTGCGGCGGGGCCGGACGCTGCTGGTCTCACCGCACCCGGACGACGTGGCGTACTCCTGCGGCGGGCTGCTGGCCGCGGTCGGCCGCCCCGCGCACGCGACGCTCCTGACGGTGTTCACCCGGTCCGCGTGGGCGCTGCCCAGACGGCTGCGGCGGGCCGGGGCGCGGGTGGTCAGCGAGCGGCGCAGGGAGGAGGAGCTGCGGTACTGCCGGCTGCGGGGCCTCGCGGAGTACCGGCCGCTCGGCTTCGCCGACGCGGGGCTGCGCGGCTACGACGACGAGACCGAGCTGTCGTCCCCGGCCGAGGCGGACGGCGTGCGCGGCGCGGTGGAGGAGGCCGTCGCCGAGGCGATACGCGACGCGGGCGCCGACACGGTGCTGGCCCCGGCCGCCGTCGGCGGGCACGTCGACCACCTCCTGGTGCACGGCGCGGTGCGCGGCGCGGTGGGCCCCGGCGGCCCGCTGACCCTGTTCTACGAGGACCTGCCGTACGCGGGGCAGCGCGACGCGGTGGACGTCGAGCGGACGCTGCGGGAGGCGCGCGGCCTGGTGCCGTTCGCGAGCGTCGACATCTCCGGTGTCGTGCAGCAGAAGGTGCGCGGCATGTACGTGTACGGCAGCCAGACGGACGACGAGTGCGTGCGCGAGACGCTGCGGCACGCCCGGCGCGGCGCGCCGCGCCGGTGGACGGGCGGGACGGCGGGGGCAGGGCATGCGGCGGGCCGCCGGGGCGCGCCGCACACCGAGCGGGTGTGGACGCCCGCCCCGGCGGGTGCCCGGTGA	MGEPTWEAAEDPDRTLRERLRRGRTLLVSPHPDDVAYSCGGLLAAVGRPAHATLLTVFTRSAWALPRRLRRAGARVVSERRREEELRYCRLRGLAEYRPLGFADAGLRGYDDETELSSPAEADGVRGAVEEAVAEAIRDAGADTVLAPAAVGGHVDHLLVHGAVRGAVGPGGPLTLFYEDLPYAGQRDAVDVERTLREARGLVPFASVDISGVVQQKVRGMYVYGSQTDDECVRETLRHARRGAPRRWTGGTAGAGHAAGRRGAPHTERVWTPAPAGAR	MPRFFTRHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAGGMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIATVGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFMHWKVLFAIIAVMGFISFVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPVILIDAGSLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLVGLSLLIVGNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNKLPKGTVSASLNMVILMVMSVSVEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELVEEQ	68.05	gnl|BL_ORD_ID|1098|hsp_num:0	1191			36	174	acriflavine; lincomycin; puromycin; chloramphenicol; norfloxacin
BGC0000710.1|Neomycin_3 # 2326 # 3426 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=6bp;gc_cont=0.779	BGC0000710.1|Neomycin_3 	2326	3426	-	Loose	275	25.7942	AAC(6')-Iid	34.88	3002589	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGGCTGAGGCGCCTGCCGGGCGGGCCCTGTTCGAGATCTACGACGAGGGCTTCGACTCGCCGTCGTGGGGCGGTGTGGAGACCGCCCTGTGGCACCTGTCGCGCTCCCTGCGCGAGGCGGGCACCGAGGCGGAGTTCTACCGGTCCTCGGAGGGCGCCGACCTGGACGCGCTGGCCGCGCGTGTGGAGCGGGACCGGGTGGACGCGGTCTTCCCGCTGGTGGAGAGCGACCTGTTCGAGGGCGCGGCATGGCGGCGGCTGCCCGCGCTGCACGCCCGGACGGTCCGCGTCTGGCATGACGTCAGCCGGCTCTCGGCCGACCTGTCGGCGCCGCCGCCCTGCCCCGTGCACGCGCGGGTACCCGCGCTGCCGGGGGCTCCGGTCGCGGAGGGCTGCCCGGCGCGGGGCGCGCACCCCGAGGGGCCGATGCGCGAGGTGTTCCTGGGCGAGTGGCCCTGGACGCGCTGCTTCCCGCGCCGGTCGGTGATCCCCTGGGCCGCCGACCACGTGCCGGCGAAGGACCTGTGCGACCCGTCCGGGCCGGTGGTGCTCCAGCTCGGCAAGATCGACACGGTGGACGCGGAGCGCTGCCTGCGCCGGCTCACCGGGGCCGGGGTGGCCCTGCGGGTCGTCTTCGCCACGTGGTCGCGCCGGGGCCGGGAGGCCCGCGAGCTGGTGCGCGCGCACCAGGGGGCGGGGCGGCGCGTCGAGGTGCTGGACGCCTACGACATCCGTACGGACTGGGAGCGGGTCTTCGGCGGCGCGTCGCTGTTCCTGCTGCCGTCCGTGTTCCACGAGACCTACAACTTCGCCGCGGCGGAGGCCGTCCAGCTCGGTGTGCCGGTGGCGGCCCTCGGCGAGGGCGGCAACCTGCCGCGCTTCGCGTCGCTGACCGCGCCGACGCCCGACGCCCTGGTGGACCGGCTGCTGGCGGGGGGCGGGGCGGTGGCGCCGCGTCCCCGCCCGGCGGCGGGCTGGCGGGACGTCGCCGCCCGGTACGCGGAGGTCATCCGGGAGCACCCGGCCGCCGGTGCCGGTCCGGCGGTCCCCGCGGGCGCCGGCGAGGGGCGGGGCGGACGGGAGGAGGAGCACGGTGGGTGA	MAEAPAGRALFEIYDEGFDSPSWGGVETALWHLSRSLREAGTEAEFYRSSEGADLDALAARVERDRVDAVFPLVESDLFEGAAWRRLPALHARTVRVWHDVSRLSADLSAPPPCPVHARVPALPGAPVAEGCPARGAHPEGPMREVFLGEWPWTRCFPRRSVIPWAADHVPAKDLCDPSGPVVLQLGKIDTVDAERCLRRLTGAGVALRVVFATWSRRGREARELVRAHQGAGRRVEVLDAYDIRTDWERVFGGASLFLLPSVFHETYNFAAAEAVQLGVPVAALGEGGNLPRFASLTAPTPDALVDRLLAGGGAVAPRPRPAAGWRDVAARYAEVIREHPAAGAGPAVPAGAGEGRGGREEEHGG	MIISEFDRENIVLRDQLADLLRLTWPDEYGTEPMKEVEQLMAPERIAVSAIEGEELVGFVGAIPQYGKTGWELHPLVVASTHRKQQIGTRLVSYLEKEVASYGGLVIYLGTDDVEGQTNLVETDLFEDTFAKLQEIKNINHHPYTFYEKLGYQIIGVIPDANGWNQPDIWLAKRVAKREPTE	201.10	gnl|BL_ORD_ID|1691|hsp_num:0	1831			252	381	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000710.1|Neomycin_4 # 3419 # 3670 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=4bp;gc_cont=0.726	BGC0000710.1|Neomycin_4 	3419	3670	-	Loose	500	22.7126	BUT-2	61.11	3005558	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	BUT beta-lactamase	ATGACCCGCATGCTCGTCGTGAAGTGCCTGAGCGACGAGACCGGCGACGACGCCGGGGACATCGTCGCCCGGGGGTGCGTGGACGTGGACGACCGCGAGTTCGTCAACATCCTCAACCGGCTGGAGGGCTACTTCGACTGCACGCTGTGGATGCGGTCGGAGCCGGCCCGGCGCTTCGCCGTCGGCGACCTGGTGGAGCGGGTCGCCGCGGTGACGGCCCCCGGCGGCCCGCCGGAGGTGCGCCGTGGCTGA	MTRMLVVKCLSDETGDDAGDIVARGCVDVDDREFVNILNRLEGYFDCTLWMRSEPARRFAVGDLVERVAAVTAPGGPPEVRRG	MMKKTLCCALVLSASFSAFAAQKTLSDKQLEEAVNQTLKPMITAQAIPGMAVAVIYQGKPHYFTYGVADIAKNQPVTTQTIFELGSVSKTFTGVLGGDIVARGEVKLSDPAMKYWPELTGKQWQGITLLDLATYTAGGLPLQVPDEVDNQAALLKFYQNWQPDWAPGTRRQYANSSIGLFGALAVKPSGMTFNDAMRQRVLQPLNLKHTWLTVPASEENHYAWGYRDGKAMHVGPGMLDTEAYGVKSTIEDMASWVQYNMNPQQVKQPTLQKGLEIAQSRYWRSGSMYQGLGWEMLNWPVAAATVINGSDNKVALAASPVTAIEPPVAPVKASLVHKTGSTNGFGAYVAFIPEKQIGIVMLANKMYPNTERVKAANTLLNTLQ	21.67	gnl|BL_ORD_ID|3338|hsp_num:0	4407			273	327	
BGC0000710.1|Neomycin_5 # 3667 # 4368 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.771	BGC0000710.1|Neomycin_5 	3667	4368	-	Loose	1050	25.0238	YojI	29.63	3003952	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACGGCCGCCCAGCGGTTCGTGCTGGTCCGGCACGCCGAGGCGAGCCTGAACGTGCTGCGCGACGACGACGTCATGCCGGGCTTCGACCCGCATGCCGGGCTGACGCCGCTCGGCGAGCGGCAGGCGCGGGCGCTCGCCGAGCACCTGCCCGGCGACCCGGCGGTAGGCCCGCCGGGTCCCGCCCCGGCCCCGCGGCCCGGTCCGGGCTCGGGGCCCCGCCCTGCCGTGCGGGTGTACTCCAGCCCGCAGCGGCGGGCCGCCCGCACCGCCGAGGTGCTGGCCGCCGCGCTGGGCGTGCCCGTCCTGGCGGACGGCCGGCTGGCGGAGCTCCGGGCGCCGCGCGCCTTCCCCCGGCCCATGACGGTCCGCCAGTGGGACGCCGTGCTGGAGGACCGGCTGCGGCGCCCGGCGGCCGAGCCGGCGGGGGTGGAGAGCTGGGCGGCGCAGCGGCGGCGCGTCCGGGAGTTCCTGGACTCCCGCTGCCCGGTCGGCGCCGACGGGGCGCGGTGGGTGCTCGTGTCGCACTCCGAGACGCTGCAGGCCGTCCTCTTCGAGCTGCTGGGGCTGGAGGACGCGCTGCTGCACCGCACCCGTTTCAAGATCAGCAACACCGGTGTGTTCATCGTGGACAGGACGGAGGACGGATGCGCTTCCCTGGTGGTGGCGAACAGCAAGACGCACCTGGCCAGGACGGCATGA	MTAAQRFVLVRHAEASLNVLRDDDVMPGFDPHAGLTPLGERQARALAEHLPGDPAVGPPGPAPAPRPGPGSGPRPAVRVYSSPQRRAARTAEVLAAALGVPVLADGRLAELRAPRAFPRPMTVRQWDAVLEDRLRRPAAEPAGVESWAAQRRRVREFLDSRCPVGADGARWVLVSHSETLQAVLFELLGLEDALLHRTRFKISNTGVFIVDRTEDGCASLVVANSKTHLARTA	MELLVLVWRQYRWPFISVMALSLASAALGIGLIAFINQRLIETADTSLLVLPEFLGLLLLLMAVTLGSQLALTTLGHHFVYRLRSEFIKRILDTHVERIEQLGSASLLAGLTSDVRNITIAFVRLPELVQGIILTIGSAAYLWMLSGKMLLVTAIWMAITIWGGFVLVARVYKHMATLRETEDKLYTDFQTVLEGRKELTLNRERAEYVFNNLYIPDAQEYRHHIIRADTFHLSAVNWSNIMMLGAIGLVFWMANSLGWADTNVAATYSLTLLFLRTPLLSAVGALPTLLTAQVAFNKLNKFALAPFKAEFPRPQAFPNWQTLELRNVTFAYQDNAFSVGPINLTIKRGELLFLIGGNGSGKSTLAMLLTGLYQPQSGEILLDGKPVSGEQPEDYRKLFSAVFTDVWLFDQLLGPEGKPANPQLVEKWLAQLKMAHKLELSNGRIVNLKLSKGQKKRVALLLALAEERDIILLDEWAADQDPHFRREFYQVLLPLMQEMGKTIFAISHDDHYFIHADRLLEMRNGQLSELTGEERDAASRDAVARTA	42.60	gnl|BL_ORD_ID|4707|hsp_num:0	2424			1137	1299	microcin J25
BGC0000710.1|Neomycin_6 # 4365 # 5264 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.681	BGC0000710.1|Neomycin_6 	4365	5264	-	Loose	900	27.335	iri	56.52	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGACCACCGACATCGTGTGGCCGCCCCCGGTGCGGCAGGTCCGCGCCTACCGCAACATCGTCGTGGACGGCGCCTGCAACATCCGGTGCACCTACTGCGAGGTCAAGAAGACCAAGGTGGACCAGCCCGCCACCATCCGTTCCCTGGACCGGATCTTCGCCGAGTACGAGCCGGACGCGGTGCTGTTCCGGGTGGAGTCCGACGGCGAGATCACCCTCTACCCGAAGATCGTCGACCATCTGCAGAAGCGGGCCGCCGAGGGGTACCGCGTCGAGGTGCTGAGCAACGGCACCAAGCTGCCCAGGGCCCTGGAGGGGCGCCCCGACCTGCTGTGGGTGTTCTCGGTCGACGGGCACACCGAGGCCATGAACGCCAAGCGCGGCCTGAAGCAGCCGCAGATCGACCGCATCCTCGACGCCGCCGTCGAGCTGGGGGCGGAGCTCCAGACCGTGTACTGGGGCCAGCCGGTGGAGGAGGTCAACGCCTACATCGACCTGCTGGAGTCCCGCGGCTACCGGGGACTGCTCCACTTCATGCCGCTGCTGGCCTTCAAGGGCCGGCCGCTGACCGTGAACCTGCGCTACCAGGACCTGCACCCGGCGGACTTCCTGGCGCCGCCGGAGTACTTCCGCCGCTGGAACCACATCTTCGAGACCGGCAGGCGGGACGCGGTCTGCGACCAGATCACCAACGGCTACAACTACCAGGTGTCCGGCGACGAGATCCGGATGGTCAAGTGCGACTGCTACTCGGTGCCCAAGCACCTGGTGCACGGCTTCGGCCCGATCCGGGAGTTCGACGACTGGCCGTGCGGGACCTGCATCGCCAACCAGGAGTTCAACAACTCGCGCGAGCGGATGCGCGTCCCGCAGGGGCGGATCCCGCTGCCGCTCGTATGA	MTTDIVWPPPVRQVRAYRNIVVDGACNIRCTYCEVKKTKVDQPATIRSLDRIFAEYEPDAVLFRVESDGEITLYPKIVDHLQKRAAEGYRVEVLSNGTKLPRALEGRPDLLWVFSVDGHTEAMNAKRGLKQPQIDRILDAAVELGAELQTVYWGQPVEEVNAYIDLLESRGYRGLLHFMPLLAFKGRPLTVNLRYQDLHPADFLAPPEYFRRWNHIFETGRRDAVCDQITNGYNYQVSGDEIRMVKCDCYSVPKHLVHGFGPIREFDDWPCGTCIANQEFNNSRERMRVPQGRIPLPLV	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	62.42	gnl|BL_ORD_ID|729|hsp_num:0	796			282	351	rifampin; rifaximin; rifabutin; rifapentine
BGC0000710.1|Neomycin_7 # 5438 # 7324 # -1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=3bp;gc_cont=0.749	BGC0000710.1|Neomycin_7 	5438	7324	-	Loose	600	26.9498	Streptomyces venezuelae rox	37.5	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGGGCGCTTCGCCGGCATGCACCGGGGCTGGCTGGCCGCCACGACGGCGTGACGCGGGCCGCCGCGCGCCGGGCGGGACACGCCCGCGCCCCGCACGCCGCGAGGCGCGCCGGGCCCGCGCTCCGGACCGGGCGCACGCCGGGGGCCCGCGCTCCGTCGCCCCGCACGGGCACTCCCCCTACGACCCCTACGACACCTACGACACCTACGACCCCAACGACCACGACGACCACGACGACCACGACGACGAAAGGCACAGGATGAAGCGCCTTCGAGGCACCCTGCCCTCGGACGCACGGCACGCGTGGCACCCGGAGCCGCTGGGTCCCGCGCACCGCGACGGCTGGGACACCCGTGACGACGACCGGGTCTGGGACGTCGTCGTGATCGGCAGCGGCGCCAGCGGCTCCGTCGCCGCGGACCGGCTCGTCCGGCAGGGCCTGGACGTCCTGATGATCGAGGAGGGCTTCCGGCTCTCCCCCGACCTCGGCAACCCCGAGCTGGACGACATGTGCCGCACGGCGCTGGCCCGTGACGGCCAGGGCGGCTGGACCGACGAGGGCTGGCCGTGGACGACGTCCAACCTCGGCGGCGGCACGGTCTTCTACGGCGGCGCCTCCTGGCGCTACCGGCCGTTCGACTTCGACCCGAGCGAGCTGGTGGACGCCGGCGGGCTCGACGTCCGCTGGCCGTACGGGCTGGCCGAACTCGCGCCGTACTACGACGTGCTGGAACGCCGGCTGGGGGTGTGCGGCGGCGAGGAGGGCGAGGGCAGCCGCGGCCCCGCGCACCCCCCGACGGCCGCGGCCGAGGTGCTCTACGAGGCGGGCACCGCACTCGGCTACGAGCCCTTCCCCACCCCGCTGGCCATCAACCGGCACGCCCACGGCGGGCGTTCGGCGTGCGAGCGCAACTCGCTGTGCGTGAGCCACCAGTGCTCGACGGGCGCCAAGGGCGACGCGGTCGCGGTCTTCCTCGCACCGCTCGCCGCGCACCCCAACTTCACCCTGCGCACCGGTGTACGGGCCCTGCGCCTGAACCAGGACCGGCCGGACGCCGTCGGTTCGGTGACCTGCCTGGACCGGCTCGGCCGCACCACGCACCGCGTCCGCGCCCGGTCGTTCGTCGTCGCGTGCAACGCGATCCAGAGCGCCGCGCTGCTGCTGCGCTCCCGCGGCGGGCGCGCCCCGGACGGCGTGGGGAACCACTCCGGCCTGGTCGGGCGCGGCCTGACGATGAAGCTGAGCGAGTACGTGAGCGGTGTGGTCGACGCGCCGTCCGCCGCGACGCTCGCCGACTGGCGCGCGCACGCGGGCCCGTTCTCCACGATCGCGTTCCTCGACCACTACCTGGACGCCGACTGCCCCACCGGGGTCGGCGGGATGATCTACGAGTCGAAGAACGACATGCCCTCGCGCATCCGCGACGACGTGCTGGAACTGCGCATCGAGACGATCCTGGCCGACCACCCGAACCTCGACAACCGGGTGCGGCTCTCCTCGCACGCCGACGAGGACGGCGTGCCGGCCGTGGTCATCGACTACACGCCCGACCCCCGCGACCTGCGCCGCCTCGCGTACATGACGGACGTGTGCGAGCGGCTGCTGCGGAAGGCGGGCGCGACCGGGATCGCGCACGAGGAGAGCGGCTTCGCCCAGGGGAGCTGCCACCTGCACGGCACGTGCCGGGCCGGCGACGACCCGGCGACGTCGGTGGTCGACGGCTGGGGCCGGGTCCACTCGGCGCCCAACGTGTACGTCGTCGACGGCGGCTTCATGCCGTACCCGGGCGGCCTGAACCCCACGCTCACCATCCAGGCGCACGCGCTGCGCAGCGCCAAGGCGGTCGCCGGCGACCTCGTGTCCCGGCACACCGCGCACGTCTGA	MGASPACTGAGWPPRRRDAGRRAPGGTRPRPARREARRARAPDRAHAGGPRSVAPHGHSPYDPYDTYDTYDPNDHDDHDDHDDERHRMKRLRGTLPSDARHAWHPEPLGPAHRDGWDTRDDDRVWDVVVIGSGASGSVAADRLVRQGLDVLMIEEGFRLSPDLGNPELDDMCRTALARDGQGGWTDEGWPWTTSNLGGGTVFYGGASWRYRPFDFDPSELVDAGGLDVRWPYGLAELAPYYDVLERRLGVCGGEEGEGSRGPAHPPTAAAEVLYEAGTALGYEPFPTPLAINRHAHGGRSACERNSLCVSHQCSTGAKGDAVAVFLAPLAAHPNFTLRTGVRALRLNQDRPDAVGSVTCLDRLGRTTHRVRARSFVVACNAIQSAALLLRSRGGRAPDGVGNHSGLVGRGLTMKLSEYVSGVVDAPSAATLADWRAHAGPFSTIAFLDHYLDADCPTGVGGMIYESKNDMPSRIRDDVLELRIETILADHPNLDNRVRLSSHADEDGVPAVVIDYTPDPRDLRRLAYMTDVCERLLRKAGATGIAHEESGFAQGSCHLHGTCRAGDDPATSVVDGWGRVHSAPNVYVVDGGFMPYPGGLNPTLTIQAHALRSAKAVAGDLVSRHTAHV	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	131.93	gnl|BL_ORD_ID|4833|hsp_num:0	5820			0	96	rifampin; rifaximin; rifapentine
BGC0000710.1|Neomycin_8 # 7272 # 9056 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGGG;rbs_spacer=9bp;gc_cont=0.751	BGC0000710.1|Neomycin_8 	7272	9056	-	Loose	1100	263.848	tetB(60)	30.87	3004036	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAGCGGCTCGGAGGACGCGCGGTCCCGCGCCCGGCGGGACGCCCTGCTGCGGATGCTGCTGTGGCCGAAGCGGCGGCGGCTGGCGGCGGCCACGGCGCTGGCGCTGCTGGAGAACGTGTGCGGGCTGGTGCCGCCGCTGCTGATCGCCGCGGCCATCGACCGCGGGGTGCCCGCGGCGGTGGACGGGCGGTGGGCGCCGCTGATCGGCTACACCGCCGCGGCGCTGGCCACCGGGCTGGCCACGGCGAGCGTCAAGTACTGCTTCCTGCGCTACTCCGGGCGGATCGCGCAGGACCTGCTGTTCGAGCTGCGGCACCGGGCGTTCGCCCAGGTGATGGGGCAGCCGCTGGCCTTCCACGAGGCGTACCCCTCGGGCCGGGTCGTGGCCCGGCTGTCGAGCGACGTGGAGTCGGTCGAGGAGATGCTGGAGATGGGCCTGGACGGCCTGTTCTCCGCGCTGTTCTCGATGGTCGGCATCCTCGCCGTGATGCTCTGGCTCGACCAGCCGATGGCGGCGGTGGTGATCGCGCTGTTCGTCCCGCTGTACGCGCTGACGCGGTGGTTCCGGCACCGGTCGCGCCGGGCCTACCGGGGCACCCGGACGGCCGTCGAGGGCGTCGTGCAGCACACCGTCGAGGCGTACAACGGCGTCCGGGCCGTGCAGGCCTTCCGCCGCGAGGAGGCGAACGCGCGGCGGCTGGACGGGCTGGACGCCCGGTACGCGGTGGCGCGGGCCGACGCCGGGCTGGTGAGCGCCGTGTTCAGCGGCGGTGTGAAGCTCATCGGCAACCTGTCGCTGGTGGGGCTGCTGACGCTGGGGGTGCTCCGCATCGACCAGGGGCACCTGGCGCTGGGCACGCTCACGGCGTTCCTGCTGTACGTGCACCGGCTGTACGACCCGATCGACGAGCTGGCGAGCTTCGCCAACGCGTTCTCGGCGGCCTCGGCCGGGCTGGAGAAGATCGGCGCGCTGTTCGTGCGCCATCCGGCGGTGGCCGAGCCGGAGCGCCCGGCGGCGCTGCCGGCCGACCCGCCGGGCGGCCGGGGCGCCGTGCGGTTCGAGGGCGTCCACTTCGGCTACGGCCAGGCGGCCCGGCCGGTCCTCTCGGGCGTCGACCTGGCGCTCGAACCGGGCCGCACGGTCGCCCTCGTGGGTACGACCGGCGCCGGGAAGTCCACCATCGCCAAGCTGGTGGCCCGGCTCTACGACCCCACGGCGGGGCGGGTCACGCTGGACGGGGTCGACCTGCGGGAGCTGGCCGACGCGGAGCTGCGCGGCGCCGTCTCGATGATCACGCAGGAGGCGTTCCTGTTCTCCGGGTCGGTGGCCGACAACATCGCCCTGGGCCGGCCGGACGCGTCGCGGGCGGAGATCCGGGCCGCCGCGGAGGCGGTGGGCGCGCACGGGTTCGTCAGCGCGCTGCCGGACGGCTACGACACCGACGTGCACAAGCGCGGCACGGGCCTGTCGGCCGGCCAGCGGCAGCTGATCGCCATGGCACGGGTGATGCTGACCTCGCCCCGCGTGCTGATCCTCGACGAGGCGACGTCCAGCATGGACACCTCCTCGGAGCGGGCCGTGCACGAGGCGCTGACCCGGGTCCTGGCCGGGCGCACCGCGGTGATCATCGCGCACCGCCTGTCCACGGTGGCCGTCGCCGACCGCGTCCTGGTGATCGAGGACGGGGCGGTGGTGGAGGACGGGCCCCCGACGCGGCTGCTGGAGGGCGGTGGGCGCTTCGCCGGCATGCACCGGGGCTGGCTGGCCGCCACGACGGCGTGA	MSGSEDARSRARRDALLRMLLWPKRRRLAAATALALLENVCGLVPPLLIAAAIDRGVPAAVDGRWAPLIGYTAAALATGLATASVKYCFLRYSGRIAQDLLFELRHRAFAQVMGQPLAFHEAYPSGRVVARLSSDVESVEEMLEMGLDGLFSALFSMVGILAVMLWLDQPMAAVVIALFVPLYALTRWFRHRSRRAYRGTRTAVEGVVQHTVEAYNGVRAVQAFRREEANARRLDGLDARYAVARADAGLVSAVFSGGVKLIGNLSLVGLLTLGVLRIDQGHLALGTLTAFLLYVHRLYDPIDELASFANAFSAASAGLEKIGALFVRHPAVAEPERPAALPADPPGGRGAVRFEGVHFGYGQAARPVLSGVDLALEPGRTVALVGTTGAGKSTIAKLVARLYDPTAGRVTLDGVDLRELADAELRGAVSMITQEAFLFSGSVADNIALGRPDASRAEIRAAAEAVGAHGFVSALPDGYDTDVHKRGTGLSAGQRQLIAMARVMLTSPRVLILDEATSSMDTSSERAVHEALTRVLAGRTAVIIAHRLSTVAVADRVLVIEDGAVVEDGPPTRLLEGGGRFAGMHRGWLAATTA	MRTMKRLLSYLRYEKKGVLIGLFCLLLSTGATLTGPLVAKHIIDNVITPMGQAHDFKAGGLLLWVGIYVTVNLVGVAGAYLNRVYMKTLSNRIAKRIRDEVFEHVQTLPVSYFDHLPAGKVVSRITSDTESVRANFYVSGISTLFSTIVMLVGVYITIFLLNATLGLVLLFLVPVMILWQRTVATKQKKYYSENRELYSQLSGQLNESIQGAGIVQAFQQEEKIVAEYDATATSWVEVGRKELILESYFSWSLVGMLRNITHFGVIYYFSMQFIGGTLGISAGLLYAFIDYINRIYEPIQTFMNVVSGFQQSMAAGDRVFELMDTPSEESGEELFTFDEGCIEFKDVSFEYTAGVPVLKHLNFTVEPGQTVAFVGHTGSGKSSIMNLLFRFYDPTSGAIFIDGKNTRDFNRRSVRSEMGIVLQDPYLFTGTIASNVGLNNESIEPETIKEAIIKVGGGHLLTKSDKGLDYEVKEKGMDFSSGERQLISFARAIVFDPKILILDEATSHIDTETEEIIQNAINVVKEGRTTFMIAHRLSTIAHADQIFVLDKGEIVERGTHDELLQLQGQYAEMVALQKG	102.59	gnl|BL_ORD_ID|2307|hsp_num:0	2646			18	1719	tetracycline
BGC0000710.1|Neomycin_9 # 9053 # 11053 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=AGGGG;rbs_spacer=7bp;gc_cont=0.779	BGC0000710.1|Neomycin_9 	9053	11053	-	Loose	1190	261.536	novA	32.85	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGGGCGCCGTGACGTCGCTGCGGCGCTGTGCGCCGTATCTGCGCCCGCACCGGGCGCTGATGGCGGGGGCGTGCGGGGCGGCCTTCGGGTCGATGCTCGCGGGCCTGGCCATGCCGCTGGTGCTCCAGCGGCTGGTCGACGGGCCGGTCGCGGAGCGGGACTTCTCCGCCCTGCCGTGGTTCATCGGCGCCTTCGCCCTGCTCGGCGTCGCCGAGGCCGTGCTGCTGGGGGCCCGGCGGCTGCTCGTCATCCGTCCGGCGACCCGCCTGGAGACGGCGATGCGGGCGGACGTGGCCGCGCACATCCAGCGCCTCCCGCTGTCGTTCCACGCCCGCTGGCAGTCCGGCCAGCTGCTGTCCAGGACGGTGTCCGACATCACGGAGATCGGCCGGTTCGTCGCGTTCTCCGCCATCTATCTGGTGGTGAACGTGGCGGCGCTCGCCGTCGGCCTGGTCGTCCTGGCGTGGCTGGCGCCGGCGCTCGCGCTGGTCGTGTTCCTCGCGTACACGCCGATGGTGGTCGCGACCACCGTCTTCGAGCAGCGGTTCCGGGTGGTGGCGCGGGCGGCGCAGGAGGTGGGGGGCGACCTGTCCACCACGGTGGAGGAGTCGGTGCTCGGCGTACGGGTGCTGAAGGTGTTCGGGCGGGCGCCGGAGACGGTGCGCCGCTTCACCGGGCAGGCGCGCCGGCTGCGCGTCCTGGAGCTGCGCAAGCTCTCGTACACGGCGGCCCTGTGGTGGGTCATCACGGCGCTGCCGGACCTGGCGATCGTGGCGATGATCGGGTACGGCGGGTACGGCGTCGCCACCGGGGCGCTGTCGCTGGGCACGCTGATGGCGGCGGTGACGGTGGCCACCCATCTGCGCTGGCCGGCGGACACGCTGGGCTGGCTGACGGCGGACGCCTCGACGGCCGCCGCCGCGGCCGACCGGTACTGGCAGGTGCGGGACGAGCCGGTGACGGTGGCGGACCCGGCCCGGCCGCGCCCCCTGCCGTCGCCGGTGCGCGGCGAGATCCGCCTGGAGGGCGTGCACTACGCCTACCCCGGTGGCCGCGCGGCGGCGCTGCGGGGCGTCGACCTGACGATCCGGGCGGGCAGCACGGTGGCCGTGGCCGGGGCGACCGGGTCCGGCAAGAGCACGCTGCTGTCGCTGCTGTCGCGGCTGGACGACCCGACGTCCGGGCGGATCACCCTGGACGGGGTGGACCTGCGCGAGACGGCCCTGGCCGACCTGCGGTCGGCGGTGTGCAACGCGTTCGACGATCCGGTGCTCTTCTCGGGCACGGTCCGGGACAACGTGACGCTGGGCGTGCGGGACGCGGAGGCGCCCGGCGCGCGGGACGCGGGGGCCCGGCCGGCGGACGGCGGCGGGGCCGGGGGCTCCGGCGGGGCGCCGGGGGCGGACGCCGGGGCCGGGACGGGGGCCGGGCGGGCGCCGGGCGGCGGGGTGCCCGACGGCGCCGTCTGGGAGGCGCTGCGGACGGTGCGGGCGGACGAGTTCGTCGCGGCGCTGCCCGAGGGGCTGTCCACCGTGATCGGCGAGGAGGGCCTCGGGCTCTCGGGCGGCCAGCGGCAGCGGCTGGCGCTGGCGCGGGCCATCCTGCCCGGACCGTCGGTGCTGGTGCTGGACGACGCGCTGTCGGCGCTGGACGTACGGACCGAACGGGAGGTGGAGGCCGCCCTGCGCGGGGTGCTCGGCCGGGTCACCACGGTCGTGGCCGCGCACCGGCCCGGCACGCTGCGCCTGGCCGACCAGGTGGTGTTCCTCTCCGGCGGCCGGGTCGCCGCCACGGGCACGCACGAGGAGCTGATGGCGCGCGAGCCGGCGTACCGGCTGCTGGTCCGGCCCCCGCTCCCGGTCGCGGCGCGGGAGACGCGGGCGCCCGGCCCCGGGGAGGCGCCGTTGCCCGGCCCGGCGGAGGCGCCGGCGGAGGCGCAGGTGCCCGCGGAGAGGGCGGTGGCGGAGGACGGCATGGCGGGAAGGGGGCGGCCGGGATGA	MGAVTSLRRCAPYLRPHRALMAGACGAAFGSMLAGLAMPLVLQRLVDGPVAERDFSALPWFIGAFALLGVAEAVLLGARRLLVIRPATRLETAMRADVAAHIQRLPLSFHARWQSGQLLSRTVSDITEIGRFVAFSAIYLVVNVAALAVGLVVLAWLAPALALVVFLAYTPMVVATTVFEQRFRVVARAAQEVGGDLSTTVEESVLGVRVLKVFGRAPETVRRFTGQARRLRVLELRKLSYTAALWWVITALPDLAIVAMIGYGGYGVATGALSLGTLMAAVTVATHLRWPADTLGWLTADASTAAAAADRYWQVRDEPVTVADPARPRPLPSPVRGEIRLEGVHYAYPGGRAAALRGVDLTIRAGSTVAVAGATGSGKSTLLSLLSRLDDPTSGRITLDGVDLRETALADLRSAVCNAFDDPVLFSGTVRDNVTLGVRDAEAPGARDAGARPADGGGAGGSGGAPGADAGAGTGAGRAPGGGVPDGAVWEALRTVRADEFVAALPEGLSTVIGEEGLGLSGGQRQRLALARAILPGPSVLVLDDALSALDVRTEREVEAALRGVLGRVTTVVAAHRPGTLRLADQVVFLSGGRVAATGTHEELMAREPAYRLLVRPPLPVAARETRAPGPGEAPLPGPAEAPAEAQVPAERAVAEDGMAGRGRPG	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	108.29	gnl|BL_ORD_ID|1112|hsp_num:0	1210			72	1785	novobiocin
BGC0000710.1|Neomycin_10 # 11041 # 12318 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.772	BGC0000710.1|Neomycin_10 	11041	12318	-	Loose	700	48.1358	LpsB	27.82	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	GTGGAGTCCCCCGTGCGTGTGCTGCGGCTCACCCCCTTCTTCCACCACGACTGCGTCACCGCCTGGCCCGCGGAGTTCGACGCCGTCGGGGGCATGCAGGTGCAGATCCTCCGCCTCTCGCGGGAACTGGCCGACCGCGGCGTGGAGCAGCTCGTCATGACCGTCGGGTTCCCCGGCCTGCCCAGGGAGCGCGTCGACCGGCCCGGCCTCCGGGTCCGGGTCACCCGGGCGCCGCTGCCCCGGCTGCGCTCCGAACTGACCGGCCTCGTGGGGCTCAACCAGGCGTGGCTCGCCGCGGTGCTGACGGCCTGTGCGCCGCTGCGCCGCACCTGGAGGCCCGACCTGGTGCACGTCCACGCGGACGGCCAGCTCTGGGCGCTGCTCGCCGGGCCGCTCGTCTCGCGTCTGGTCGGCGCGCCGTACTGCCTCACCCTGCACTGCTCGCGGCTGGCCTCGTACGAGCCGATGTCCCGCTTCGACCGGCTCCAGCACCGGCTGGTGGCGGCGGCCGAGCGGTACGCGCTGCGGCGGGCGCGCCGGGTGTCGACGCTGACCTCGCGCACCGCGGACACGGTGGCGCGGCTGCTGCCGCTCGACCGGGCCCTGGTGGACGTGCTGCCCGACTCGGTCGGCGACGTGCGGCCGGTGGCGCGGCCGGAGGCCGAGGAGTACGTGCGGTCGCTCGGCGTGCCCGCCGGGCGGCCGGTGGTGGGCTGGGTCGGCCGGGTCGCGCACGAGAAGGGGTGGCGGGACTTCGTCGCGATGGCGGAGCGGTGGGACGCCGGGTCGGGCGCCCCGGGGGCGGTGTTCGCCGTGGTGGGCGACGGGCCGCAGCGGGAGCGGATGCGGGAGGCGGTCGAGGCGGCGGGGCTCGCGGACCGGTTCGTGTTCACCGGTTTCCTGCCCCATGACGCCGTGCCGTCCGTGATGACGGCGCTGGACGTCCTCGTCATGCCGTCCGCCCACGAGGAGCTGGGCGGCAGCGCGCTGGAGGCCATGGTGTGCGGCACGCCCGTCGCGGGCTACGCGGTCGGCGGGCTGCGCGACACGGTCGGCTCGGTCACGCCCTCCCTGCTCGTCCCGCGGGGCGACGTGGCGGCGCTGACCCGCGCCGCCGGCGACGCGGTCACGGACGCCGAACGGCACCGCAAGACGGTCGCGGCGGCCGTTCCCGACCTGCTGGGCCGGTACGGCGCGGACACCGTCGAGCGGGCGCTGGAGCACTACCGGCTGGCCGTCGGCCGGGCGTCCGGAGGGGGTGCCGGGTGGGCGCCGTGA	MESPVRVLRLTPFFHHDCVTAWPAEFDAVGGMQVQILRLSRELADRGVEQLVMTVGFPGLPRERVDRPGLRVRVTRAPLPRLRSELTGLVGLNQAWLAAVLTACAPLRRTWRPDLVHVHADGQLWALLAGPLVSRLVGAPYCLTLHCSRLASYEPMSRFDRLQHRLVAAAERYALRRARRVSTLTSRTADTVARLLPLDRALVDVLPDSVGDVRPVARPEAEEYVRSLGVPAGRPVVGWVGRVAHEKGWRDFVAMAERWDAGSGAPGAVFAVVGDGPQRERMREAVEAAGLADRFVFTGFLPHDAVPSVMTALDVLVMPSAHEELGGSALEAMVCGTPVAGYAVGGLRDTVGSVTPSLLVPRGDVAALTRAAGDAVTDAERHRKTVAAAVPDLLGRYGADTVERALEHYRLAVGRASGGGAGWAP	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	116.12	gnl|BL_ORD_ID|2781|hsp_num:0	3793			594	984	colistin A; colistin B; defensin
BGC0000710.1|Neomycin_13 # 15269 # 16291 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=9bp;gc_cont=0.754	BGC0000710.1|Neomycin_13 	15269	16291	-	Loose	400	30.8018	salD	21.58	3007028	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	sal-type ABC-F protein	ATGAAGGCTCTGGTGTTCGAGGCCCCCGAGCGGGCCGTCCTCACCCACCGCGACATACCCGCCCCGGCGCCCGGCGAGGCGCTCGTCCGCGTCGCCTACAACTCCGTCTGCGGCAGCGACCTCTCCTTCTACAAGGGCGTCTGGCACGGCTTCACCTACCCCGTCGTCCCCGGCCACGAGTGGAGCGGCTCCGTGGTGGACGTCAACGGCCCGCGCGGCGCCGACCTGGTCGGCCGCAACGTGGTCGGCGACCTGACCTGCTCCTGCGGCACCTGCGCGCACTGCGCGGCCGGCACCCCGACGCTCTGCGAGGACCTCGGGGAGCTGGGCTTCACCCGCGACGGCGCCTGCGCCGAGTACATGACCGTCCCCGTCGCCAACCTGCGTCCGCTGCCCGACACGCTGCCGCTGCGTACCGCCTGCCAGGTCGAGCCGCTGGCGGTCGCGCTCAACGCGGTGGACCGGCTCGGCGTCACCCCCGGCGAGAAGGTGGCCGTCATGGGCGCCGGCGGCATCGGGCTGCTCCTCGTGCAGGCGGTGCGGCTGCGGGGCGGCACCGTCACGGCGGTGGCCGAGCCGGTGCCCGAGCGCCGCGCCGCCGCCCTCGCCCTGGGCGTGCCCGCCGCGGTCGGCGGCGATCCGGGCGCGCTGGTCGAGCTGACCCGCTCCGACCCCGCGGCGGTGCCGGACGTCGTCCTGGAGGCGTCCGGCTACCCCACGGCGGTGCAGGAGGCGGTGGAGGCCGTCCGCCCCGGCGGACGCGTCGGCCTGGTCGGCTACCGCATCGAGGAGGCCGCGGTGATGGCCCCGCACCACATCGTGCTCAAGGTGCTCACCGTCCGGGCGTCCATGGGCCCCGGCACCCGCTTCGAGGAGGCGGTCGACGTCCTGGCCTCCGGCGCCGTCGACGTGGACGCCCTGCTCAGCCACGAATTCGCGCTCGACGACTACGCCAAGGCCCTGGACGTGGCGCTGCGCCGCGCCGACGGCAACACCCGCTCCTACTTCAACCTCCGGGCCTGA	MKALVFEAPERAVLTHRDIPAPAPGEALVRVAYNSVCGSDLSFYKGVWHGFTYPVVPGHEWSGSVVDVNGPRGADLVGRNVVGDLTCSCGTCAHCAAGTPTLCEDLGELGFTRDGACAEYMTVPVANLRPLPDTLPLRTACQVEPLAVALNAVDRLGVTPGEKVAVMGAGGIGLLLVQAVRLRGGTVTAVAEPVPERRAAALALGVPAAVGGDPGALVELTRSDPAAVPDVVLEASGYPTAVQEAVEAVRPGGRVGLVGYRIEEAAVMAPHHIVLKVLTVRASMGPGTRFEEAVDVLASGAVDVDALLSHEFALDDYAKALDVALRRADGNTRSYFNLRA	MSFYFTEKPFERFGKTLIEEVNLSVEPGEHIAIVGDNGVGKSTLLNAIYNKYNDSTYLMDQELSKYKNETAINYIMSWYPELLDIKLAMQTDYEKIGDYIELNGYEIEEQIILQAKQLNLEESDLDKQMGQLSGGQQTKVALVRAMISEKNLILLDEPTNHLDKQMIHIVVDYIKQAKQSILYVSHHRGFIDETATHIIEITPQATRKFTGNYSQYKSIIDVERETQKKVYEKKQKEIKALEATVDRVKNWHKTANQSASVRNPLEQKRLSKLAQKAKVKESQINQKLEKIKVQQPKSDDRHFHFENQDALNKKYLMQLYDFSITIDGKNIYQNANFEIKDNENIILTGPNGSGKSLLISIIKQSIIPDEGDIYITPSLKIAYFDQKNDNLNYDSTALTMLLNMEGMERSQAQTILASFGFDNQKINLPISQLSMGEKSRLQFVLLYFSNPHLLILDEPTNYFDIATQDLILQMLKQFAGQVMIVTHDEYLKSQITATHWTIKDKKLMNLTLSEKHSPNMVDDTLKLLDDYKSIDEFGHFETDN	62.50	gnl|BL_ORD_ID|4727|hsp_num:0	5739			63	393	lincomycin; virginiamycin M1; tiamulin; retapamulin
BGC0000710.1|Neomycin_14 # 16503 # 17030 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=AGGGGA;rbs_spacer=9bp;gc_cont=0.708	BGC0000710.1|Neomycin_14 	16503	17030	+	Loose	700	24.6386	CMY-49	31.65	3002060	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGGCGGGCAGTGGATCGGCCCCCGAGCCGTCGGAGCGTCCGCTCCTGCGGAGGTTCGACCAGCGGCTCAACGAGCTGATCGCCGCCCTGTATCCGGACGAGCGCAGACGACCGGGGTACGCCCGGCTGGCCAAGGAGATCCGCGAGACCACGGGCGGTGCCATCTCCGGCACCTATCTCTGGGAGCTGGCCACGGGCAAGAAGCGCAACGTCACGCTGGAGCAGCTGGACGTGCTGGCCGAGTTCTTCGGGGTGCCCCCCGAGTACTTCCTCAACGAGGAGACGGCCGCACGCGTCAACTCCCAGCTCAAGCTGGCGACCGCGCTGCGCGACTCGCGCGTGCGCAACCTCGCCCTGCGGGCCGAGGGGCTGTCCCCGGAGAGCCTGGACGCCCTGCTCATCATGGTGCAGGAGGCGCGCAGGGTGCAGAACCTCGCATCGGTCGACGACCAAGACCACACGGACCGCACGGACCACACGGCCGCACCGGACGGCGGCCCGGCCGGAACGTCCGGGAGCACGGCGTAG	MAGSGSAPEPSERPLLRRFDQRLNELIAALYPDERRRPGYARLAKEIRETTGGAISGTYLWELATGKKRNVTLEQLDVLAEFFGVPPEYFLNEETAARVNSQLKLATALRDSRVRNLALRAEGLSPESLDALLIMVQEARRVQNLASVDDQDHTDRTDHTAAPDGGPAGTSGSTA	MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVTPGQLDAEAYGVKSNVTDMARWIQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALHTVEVNPPAPAVKASWVHKTGSTGGFGSYVAFIPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	45.93	gnl|BL_ORD_ID|1383|hsp_num:0	1501			654	885	
BGC0000710.1|Neomycin_15 # 17892 # 18413 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.734	BGC0000710.1|Neomycin_15 	17892	18413	+	Loose	775	28.4906	CMY-107	35.09	3002119	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGTCGTACAGGATCGCCAGGCTGCGGCGACGCTGCCGCCCCCTGCTGGACCAGCTCGTCCTGCCCCGCCCCTTCTCCCTCGAACCGCTCTGCGCCCAGCTCTCCGCCCGGCGCGGACGCCCCCTCCACCTGCACCCGCTGCCGATCCAGGCCGCCGCGGCGGGGACGTGCGGCCTCTGGCTCGCCACCGACACCGACGACCACATCTTCTACGAGCAGCGCACCGCCCGCCCCCACCAGGAGCACATCGTGCTCCACGAGATCGGCCACATGCTGTTCGACCACCACACCGTCGACGCGGGCCCCGCCGGGCTGCCCGGCCGTCTCTTCGGCGACCTGAGCCCGCGCCTCGTACGCCGCGTCCTGGGCCGCACCGACTACTCCACCCGCCAGGAGCAGGAGGCCGAGATGCTGGCCACCCTGATCCGCACCGGCGACACCGCGCACGGCCGGTGCCTCCCGCCGGACCCCTACGGCAAGCTGCACGAGGCCCTCGGAATGGCCGGCGACCATGACCTCTGA	MSYRIARLRRRCRPLLDQLVLPRPFSLEPLCAQLSARRGRPLHLHPLPIQAAAAGTCGLWLATDTDDHIFYEQRTARPHQEHIVLHEIGHMLFDHHTVDAGPAGLPGRLFGDLSPRLVRRVLGRTDYSTRQEQEAEMLATLIRTGDTAHGRCLPPDPYGKLHEALGMAGDHDL	MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDCAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	45.41	gnl|BL_ORD_ID|2874|hsp_num:0	3892			561	729	
BGC0000710.1|Neomycin_16 # 18403 # 19698 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=13bp;gc_cont=0.777	BGC0000710.1|Neomycin_16 	18403	19698	+	Loose	950	27.335	tcr3	41.86	3002893	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCTCTGACTTACCGGGGAACCTGGGCCGCGTACTCCAGACCGCCGGCGTGCTCCTGCTGTGGGCCGCCGTGCTGCTGCGGGCCCGCCCCGCCGCCCGCCACCCGGGCCAGCGCGGACTGTGGCTCGCCGTGGCCTGCGCGGCCGCCGCGCTCACCCTGCACCTGGAGGCCGTGAGCGCGTACGCCGCCGCCCTCACCGGCTCCCCGCGCGCCGTCGGCCTCGTCAAGAACCAGGCGGGCATCGTGAGCGCCGGCGCCATCCTGCACTTCGCCGTGCACACCACCGGGAGCCGGCGCCGCACCGGCGCGGTCCTCGCCACCACGGCCGCCGTGATGGCCGCCCTCCTGGCGCTCGCCGGCCTCGGATCCCCGCACGCGCCGGGCCACGGCCCGTACCCCACGCTCGCCTGCCCCCGCTGCGCCGCCTACTGGCTCCTCCTCGTCACCGTGCACGTCGCGGCCTGCGCCCTGTGCGCCCGGGTCTGCTGGAGGTACGGCCGCAGCGGCCCCCACCGGAGCGTCAACCTCGGCCTGACGCTGCTGGGCTGGGGCTCGGCCTCGGCCGGGCTGTACTGGCTGGCCCACTACTACCTGATGGCCGTCGAAGGCCGTCCCGGCGGGGTGCTCCGCCTCGTCCTGAGCGCGCACGCCGTGCTGTGTGCCGCCGTGCTCATGGTGCCCACCGCCCTGCAGCTGCGCCGCGCCGCCGGCCACGCCCGCACCGTCTGGCGGATCTGGCCGCTCTGGCGGGACCTGGTGGAGGCGGTGCCGCACGTCGCCCTGGCCGGCACCCGCTGCCGCCCCCTGACCCTGCTGCGGCCCCAGCTCCCCTGGCGGCAGCTCGCCTACCGGAAGGTCATCGAGGTCCGCGACGCCCTCCTCGTCCTGAGCCACTACACCGATCCGGCCGTTTCCCGCGCCGCCCGCGCCCACGTGGCGCGGTGGGGGATTCCGGCCGAACGCGCCGACGCCCATGTGACCGCCTGCGTGCTGCGCGGCGCCCGCGCCGCCAGGCTCGCCGGGGCGGACCCGGACCCGGCCGCCGAGGTCCTCGCCGCCGACCGGGAGGCGTGCGGCCTCGCCGCCGAGACCGCCGTCCTGCTGCGGCTCACGGAGGCGTACCTCTCGCCCTGCGCGCGGGCCTTCGACCCCGCCGGGACCTCCGGCACCGGGCCCGCGGGCGACGCCGGGCGCACCGGGTCCGCCGGCGCCCCCCCACCCCGCACAAGAATGTCCGAAACCCCTACGGGCCCCGACGAAAGGCGCGGAACGGCGTCTCCGCCTCTGCCATGA	MTSDLPGNLGRVLQTAGVLLLWAAVLLRARPAARHPGQRGLWLAVACAAAALTLHLEAVSAYAAALTGSPRAVGLVKNQAGIVSAGAILHFAVHTTGSRRRTGAVLATTAAVMAALLALAGLGSPHAPGHGPYPTLACPRCAAYWLLLVTVHVAACALCARVCWRYGRSGPHRSVNLGLTLLGWGSASAGLYWLAHYYLMAVEGRPGGVLRLVLSAHAVLCAAVLMVPTALQLRRAAGHARTVWRIWPLWRDLVEAVPHVALAGTRCRPLTLLRPQLPWRQLAYRKVIEVRDALLVLSHYTDPAVSRAARAHVARWGIPAERADAHVTACVLRGARAARLAGADPDPAAEVLAADREACGLAAETAVLLRLTEAYLSPCARAFDPAGTSGTGPAGDAGRTGSAGAPPPRTRMSETPTGPDERRGTASPPLP	MGMANATSQTGEAVADEAGGPAGFTHRQIITALSGLLLAVLLAALDQTIVSTALRTIGDQLHGQTVQAWVITGYLVSSTIAMPFYGKLSDIYGRKPLYLAAIAVFIVGSAACAMANSMETLAIARVLQGFGGAGLMSLPTAVIADLAPVRERGRYFSYLMMAWVAASVLGPLVGGLFAGAGEILGVTGWRWAFLINVPLGLVALLSVRKALNLPHRRVDHPIDFRGALTLALCLVPLLIVAEEGLDWGWGSARSLTLFAVSLIGLVLFVLAERARGLEAMVPLRLFRRGGITMATAVNFTIGVGIFGTVSTLPLFLQLVQGRSATVAGLVIIPVMTGAIVSQTICAKIIKKWNRYKKPAIVGLGSMAGALLSLSAAGADTPLAVIVVIAAWLGFGIGLSQTVITLAIQSSAPKSELGVANAASGLFRQLGGTSGAAVFMSVLFGVAAGRLDGADPDEAVRRALSDPGSTGGLSASAVDAFTSGFDTMFLVGGLILAVGFLLTFPLRELRDEE	84.18	gnl|BL_ORD_ID|592|hsp_num:0	652			1302	1431	tetracycline
BGC0000710.1|Neomycin_17 # 19695 # 20513 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.730	BGC0000710.1|Neomycin_17	19695	20513	+	Strict	500	535.798	APH(3')-Va	99.63	3002649	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGATGCCGCCCATGGACGACAGCACGTTGCGCCGGAAGTACCCGCACCACGAGTGGCACGCAGTGAACGAAGGAGACTCGGGCGCCTTCGTCTACCAGCTCACCGGCGGCCCCGAGCCCCAGCCCGAGCTCTACGCGAAGATCGCCCCCCGCGCCCCCGAGAACTCCGCCTTCGACCTGTCCGGCGAGGCCGACCGGCTGGAGTGGCTCCACCGCCACGGGATCCCCGTCCCCCGCGTCGTCGAGCGCGGTGCCGACGACACCGCCGCGTGGCTCGTCACGGAGGCCGTCCCCGGCGTCGCGGCGGCCGAGGAGTGGCCCGAGCACCAGCGGTTCGCCGTGGTCGAGGCGATGGCGGAGCTGGCCCGCGCCCTCCACGAGCTGCCCGTGGAGGACTGCCCCTTCGACCGGCGCCTCGACGCGGCGGTCGCCGAGGCCCGGCGGAACGTCGCCGAGGGCCTGGTGGACCTCGACGACCTGCAGGAGGAGCGGGCCGGGTGGACCGGCGACCAGCTCCTGGCGGAGCTCGACCGCACCCGTCCCGAGAAGGAGGACCTGGTCGTCTGCCATGGCGACCTGTGCCCCAACAACGTCCTGCTCGACCCCGGGACCTGCCGGGTCACCGGCGTGATCGACGTCGGCCGCCTCGGGGTCGCCGACCGCCACGCCGACATCGCCCTGGCCGCCCGCGAGCTGGAGATCGACGAGGACCCCTGGTTCGGCCCCGCCTACGCCGAGCGGTTCCTGGAGCGGTACGGCGCCCACCGCGTCGACAAGGAGAAGCTGGCCTTCTACCAGCTTCTCGACGAGTTCTTCTGA	MMPPMDDSTLRRKYPHHEWHAVNEGDSGAFVYQLTGGPEPQPELYAKIAPRAPENSAFDLSGEADRLEWLHRHGIPVPRVVERGADDTAAWLVTEAVPGVAAAEEWPEHQRFAVVEAMAELARALHELPVEDCPFDRRLDAAVAEARRNVAEGLVDLDDLQEERAGWTGDQLLAELDRTRPEKEDLVVCHGDLCPNNVLLDPGTCRVTGVIDVGRLGVADRHADIALAARELEIDEDPWFGPAYAERFLERYGAHRVDKEKLAFYQLLDEFF	MDDSTLRRKYPHHEWHAVNEGDSGAFVYQLTGGPEPQPELYAKIAPRAPENSAFDLSGEADRLEWLHRHGIPVPRVVERGADDTAAWLVTEAVPGVAAAEEWPEHQRFAVVEAMAELARALHELPVEDCPSDRRLDAAVAEARRNVAEGLVDLDDLQEERAGWTGDQLLAELDRTRPEKEDLVVCHGDLCPNNVLLDPGTCRVTGVIDVGRLGVADRHADIALAARELEIDEDPWFGPAYAERFLERYGAHRVDKEKLAFYQLLDEFF	101.49	gnl|BL_ORD_ID|30|hsp_num:0	38			0	804	neomycin; ribostamycin; paromomycin
BGC0000710.1|Neomycin_18 # 20658 # 21086 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.755	BGC0000710.1|Neomycin_18 	20658	21086	-	Loose	700	24.2534	pp-flo	40.0	3002812	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCCATGCGCCGCGCAGGTCTCGTCGCCGTCGCCACCGCGCTCACCCTCGGAGCCGCCGGCCAGAGCTGGGCGACCACGTCGACCGGCGACGTCGCCGCCGGATGGGGTGACCGGGCCCGCCTCCGGGTGACCTGGGTGGACCGCACCTCCTTCGAGGGCGGGAGCCTCGCCGTCACCGACCGGACCTGCGACGGCCGGTCCTTCTACGCCACGCTCACCCTCCACACCGGCTCCGGCGCCGTCCGCTCGCTGGGCGAGCGGCACCACACCGGCGGCTGCGGCACCCGCACGGTCCACAGGGACATCGCGGCCACCGACGCGAGCGGAGTCCGCGGCATCACGATGGCCCTGTGCCGCGCAACGGCCGGAGCCCCCGGCCAGTGCGAGACCCGGTACCTCGCCGCCAACCCGTACCACGGCCTCTGA	MPMRRAGLVAVATALTLGAAGQSWATTSTGDVAAGWGDRARLRVTWVDRTSFEGGSLAVTDRTCDGRSFYATLTLHTGSGAVRSLGERHHTGGCGTRTVHRDIAATDASGVRGITMALCRATAGAPGQCETRYLAANPYHGL	MTTLHPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMVMLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAMLVATFATVRDVYANRPEGVVIYGLFSSVLAFVPALGPIAGALIGEFLGWQAIFITLAILAMLALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLIGQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCGRVGWRCLFAAVLLGIGELYGSLNSSPSSYRCGLSRSVLSSRCPLPRTALLAEFDDIAGSAVAFYFCVQSLIVSIVGTLAVALLNGDTAWPVIC	37.97	gnl|BL_ORD_ID|1895|hsp_num:0	2058			231	321	chloramphenicol; florfenicol
BGC0000710.1|Neomycin_19 # 21747 # 23744 # -1 # ID=1_19;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.781	BGC0000710.1|Neomycin_19 	21747	23744	-	Loose	500	29.6462	CTX-M-94	35.19	3001954	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	CTGGCGCGGGGGGCTCTGGAGGAGGCCGAGGGCCTGCTGGGGAGGGCGCTCGACGCGTACCGGACGGACGGTGACCGGGCCGGCGTGGCGGCGGCCTCCCTCGACCTGGCCGCCGCGCTCACCCGGCTCGGCCGGACCGGCGAGGTGTTGCGGGCGGTGCTGGAGGCGTTCGGCGGCTACCCGGACTCGGTCCCCCACCCGCTGATGCGCGGGGGCCTCCTGGCCCTGGAGGAGGCACTGGCCACGGCCGGGCGGTACGGGGAGCTGCTGTCCGCGCAGGAGGCGCTGCGCGCCCAGTACGCGACGGAGGGCGGCGACCGGCGGGCCGAGGGGCTGCTCCTCACCCGGACGGCGCGGACGCTGATCAGGCTGGGCCGCCTGGGCGAGGCCCGCGAGGCGGCGCGGACGGCGCTCGGTCACCTGGCAGGCGCCGCGGATCTGGAGGGTGACCGGGAGGAGGCCCGGCGGCTGCTGGCCGAGGCGGGCGGCGGGGACGCGGGGACGCACGGGGCCCGCACCATCGTCGCCCTGGACACGGGCGGCGACCACATCGCGGCGGGGCGGGCCCTGTCGCTCGCGCTCGCCATGTCGCGGGGGGAGGGTGCCATCGGTCCGGCCGACCACCGGATGGTGGTCGAGGAGGCCCACTGCCTGGCGGTGCTGCCGTCCGGAGCGCCGGTCGGGGAGCTGGTCACGGGGCTGGCGCGGTGGCTGCCCGACGAGCTGGAGGCGGCCGGGGCCAGCCCCGCCGCGCGCCTCGCGGTGCACACGGGGACCGTCGAGGAACGCGGCGGGCGGATCGACGCGTCCGGGCTGAACGTCCGGCTCGCGGTGGCCATGACGCGGTCGGCGGAGTTCCGGTCGCTGTCCGAGAACTATCCGTTCCACTCGACCGTGTGCCTCTCCCCCGAGGCGTTCGCCCTGCTCGGCGGGGACGGCGCGGGAGGCGGGAGGCGGGACGGCGGTCCGGGCGGCGACCGGGCCCGGCGCCGCGACGGGGGCGCGGAGCGCGATGAGGCCGGGAGAACGGGCGGGGCCGGGCCGGTCGCCGGGTTCAGGGTGCACGAGGTGTCCGAGGGCGGCCGGGCCGTGTGCTTCGTCCTCACCCCGCGCCTCGACCTGTCGGCGTACGACGCCGAACTGCTGATGGCGGCGCGGCTCTTCGCAGACGCCGACCCGGACGGGCGGCTCATGGCCGCCGCGCTGCGGAAGTCGATCGACTCGGTGCTCGACCCCGAGCGCACCGGCCGCTACGACCCGAACGACCTGGACGAGCGGGAGAAGTCGCTGATCAGCGCTCTCCTGGAGCAGGAGCTGCGCGCGTCGTTCCCCGGGCTGCCGGGTTTCCGGCTGCGGCTGTTCCTGTCGGGGCACGACTGGGCGTTCCCCCAGATCTGGGACAGCGGCATCTGTCTGCTCGTCCGGGCCGACGAGGAGCACGCCCGCTGGTCGGTGGGGCTGCTGCGGACCCGGCCCGGCATGACGGTGGCGCCCGTGAACCGGGACGCGCCGTCGCCGCTGACCACGGAGGCCCGCGAGGCGGTGCTGTGGCTGCACCGCTCCGCGCCGCTGCGGGAGAACCTGCTGCTGCGCCTGCCCGAGCGGGACCGCGTGGCGATCCTGGCCCCCGCGTCCGGGGCCGACCGCACGGCGGAGCTGTTCCGGCGGGTGCGGGAGCGGCCGGTGCCCGAGGCGGCGCTGCGGGCCGTGACCAGGCGTCGCGACAACGCCCGCACGGTACGGGAGGCGGCGGCCGTGCTCCGGGAGGAGGGCGTGCTGGTCGTGGGCGGCAACCGGCGGGGCAGGGAGCTGGCCGGGGCGCTGCGCCTGCCCGTGCCGGACGCCGACGCGTACGTGAGCGTGCGGCTGACCCGCCGCCGCCCGCACCACGCGGCGCCGTCGATCGTGGCGGGGGGCGTGGCCTGGGTCGCGGCGGGCCCGGACGACCCGCTGGAGCCGCTGCCCGGCGACCTGCCGAACCCGCGGCGGCCGCGCTGA	LARGALEEAEGLLGRALDAYRTDGDRAGVAAASLDLAAALTRLGRTGEVLRAVLEAFGGYPDSVPHPLMRGGLLALEEALATAGRYGELLSAQEALRAQYATEGGDRRAEGLLLTRTARTLIRLGRLGEAREAARTALGHLAGAADLEGDREEARRLLAEAGGGDAGTHGARTIVALDTGGDHIAAGRALSLALAMSRGEGAIGPADHRMVVEEAHCLAVLPSGAPVGELVTGLARWLPDELEAAGASPAARLAVHTGTVEERGGRIDASGLNVRLAVAMTRSAEFRSLSENYPFHSTVCLSPEAFALLGGDGAGGGRRDGGPGGDRARRRDGGAERDEAGRTGGAGPVAGFRVHEVSEGGRAVCFVLTPRLDLSAYDAELLMAARLFADADPDGRLMAAALRKSIDSVLDPERTGRYDPNDLDEREKSLISALLEQELRASFPGLPGFRLRLFLSGHDWAFPQIWDSGICLLVRADEEHARWSVGLLRTRPGMTVAPVNRDAPSPLTTEAREAVLWLHRSAPLRENLLLRLPERDRVAILAPASGADRTAELFRRVRERPVPEAALRAVTRRRDNARTVREAAAVLREEGVLVVGGNRRGRELAGALRLPVPDADAYVSVRLTRRRPHHAAPSIVAGGVAWVAAGPDDPLEPLPGDLPNPRRPR	MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQTLYRADERFAMCSTSKVMAAAAVLKQSETQKGLLSQRVEIKPSDLINYNPIAEKHVNGTMTLGELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDPRDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGSGGYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY	228.52	gnl|BL_ORD_ID|414|hsp_num:0	459			312	474	
